Product NDC: | 59630-710 |
Proprietary Name: | Orapred |
Non Proprietary Name: | prednisolone sodium phosphate |
Active Ingredient(s): | 15 mg/5mL & nbsp; prednisolone sodium phosphate |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59630-710 |
Labeler Name: | Shionogi Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075117 |
Marketing Category: | ANDA |
Start Marketing Date: | 20001214 |
Package NDC: | 59630-710-08 |
Package Description: | 237 mL in 1 BOTTLE, GLASS (59630-710-08) |
NDC Code | 59630-710-08 |
Proprietary Name | Orapred |
Package Description | 237 mL in 1 BOTTLE, GLASS (59630-710-08) |
Product NDC | 59630-710 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | prednisolone sodium phosphate |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20001214 |
Marketing Category Name | ANDA |
Labeler Name | Shionogi Inc. |
Substance Name | PREDNISOLONE SODIUM PHOSPHATE |
Strength Number | 15 |
Strength Unit | mg/5mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |